Published in Hepatitis Weekly, November 4th, 1996
"The experience with this patient argues for further investigation and clinical trials of agents such as lamivudine in patients who are coinfected with hepatitis B virus (HBV) and HIV," researchers Steven M. Schnittman and Phillip F. Pierce wrote ("Potential Role of 3TC in the Clearance of Chronic HBV Infection in a Patient Coinfected with HIV-1," Clinical Infectious Diseases, September 1996;23:638-639).
A 35-year-old male homosexual with known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-11-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.